OMER Omeros Corp
Price (delayed)
$8.01
Market cap
$465.09M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.7
Enterprise value
$884.97M
Omeros is a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market and orphan indications targeting inflammation, complement-mediated diseases, disorders of the central nervous
Highlights
The debt is up by 17% year-on-year but it has declined by 2.3% since the previous quarter
Omeros's quick ratio has plunged by 64% YoY and by 47% from the previous quarter
The EPS has declined by 44% year-on-year and by 17% since the previous quarter
Key stats
What are the main financial stats of OMER
Market
Valuations
Earnings
Shares outstanding
58.06M
Market cap
$465.09M
Enterprise value
$884.97M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$169.26M
Net income
-$156.82M
EBIT
-$132.14M
EBITDA
-$131.19M
Free cash flow
-$148.97M
Per share
Balance sheet
Liquidity
EPS
-$2.7
EPS diluted
-$2.7
Free cash flow per share
-$2.56
Book value per share
-$3.15
Revenue per share
$0
TBVPS
$4.76
Total assets
$277.08M
Total liabilities
$459.69M
Debt
$423.28M
Equity
-$182.61M
Working capital
$54.59M
Debt to equity
-2.32
Current ratio
1.69
Quick ratio
1.23
Net debt/EBITDA
-3.2
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-45.3%
Return on equity
N/A
Return on invested capital
-18.3%
Return on capital employed
-66.9%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
OMER stock price
How has the Omeros stock price performed over time
Intraday
1.26%
1 week
-5.99%
1 month
-4.76%
1 year
162.62%
YTD
-18.93%
QTD
-2.55%
Financial performance
How have Omeros's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$169.26M
Net income
-$156.82M
Gross margin
N/A
Net margin
N/A
The net income has contracted by 33% YoY and by 17% from the previous quarter
Omeros's operating income has decreased by 2.9% YoY but it has increased by 2.4% from the previous quarter
Growth
What is Omeros's growth rate over time
Valuation
What is Omeros stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has declined by 44% year-on-year and by 17% since the previous quarter
OMER's equity is down by 18% since the previous quarter
Efficiency
How efficient is Omeros business performance
The ROA has plunged by 88% YoY and by 25% from the previous quarter
Omeros's ROIC has plunged by 68% YoY and by 28% from the previous quarter
Dividends
What is OMER's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for OMER.
Financial health
How did Omeros financials performed over time
The total assets is 40% less than the total liabilities
Omeros's quick ratio has plunged by 64% YoY and by 47% from the previous quarter
The current ratio has plunged by 59% YoY and by 43% from the previous quarter
Omeros's debt to equity has soared by 84% YoY and by 17% from the previous quarter
OMER's equity is down by 18% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.